UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13D-1(a)
AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(a)
(Amendment No. 1 )*
- -------------------------------------------------------------------------------
Rheometric Scientific, Inc.
- -------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- -------------------------------------------------------------------------------
(Title of Class of Securities)
762073104
---------------------------------------------------------------------
(CUSIP Number)
Mary Diehl
13 Beverly Drive, Belle Mead, New Jersey 08502 (908) 359-7161
- -------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
October 3, 1997
- -------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box / /.
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
SCHEDULE 13D/A
- ------------------------- --------------------------
CUSIP No. 762073104 Page 2 of 5 Pages
- ------------------------- --------------------------
- -------------------------------------------------------------------------------
1 | NAME OF REPORTING PERSON
| S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
|
|
|
- -------------------------------------------------------------------------------
|
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_|
| (b) |_|
- --------------------------------------------------------------------------------
3 | SEC USE ONLY
|
- --------------------------------------------------------------------------------
4 | SOURCE OF FUNDS*
|
| Not Applicable
- --------------------------------------------------------------------------------
5 | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
| TO ITEMS 2(d) OR 2(e)
| |_|
- --------------------------------------------------------------------------------
6 | CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
- --------------------------------------------------------------------------------
| 7 | SOLE VOTING POWER
| |
| | 572,000 Shares
NUMBER OF SHARES |-----|--------------------------------------
BENEFICIALLY | 8 | SHARED VOTING POWER
OWNED BY EACH | |
REPORTING PERSON | |
WITH |-----|--------------------------------------
| 9 | SOLE DISPOSITIVE POWER
| |
| | 572,000 Shares
|-----|--------------------------------------
| 10 | SHARED DISPOSITIVE POWER
| |
| |
- --------------------------------------------------------------------------------
11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
| 572,000 Shares
- --------------------------------------------------------------------------------
12 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
| SHARES*
| |_|
- --------------------------------------------------------------------------------
13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
| 4.35%
|
- --------------------------------------------------------------------------------
14 | TYPE OF REPORTING PERSON*
|
|
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ------------------------- --------------------------
CUSIP No. 762073104 Page 3 of 5 Pages
- ------------------------- --------------------------
13D/A
Item 1. Security and Issuer
The class of equity securities to which this statement relates is the
Common Stock (the "Common Stock") of Rheometric Scientific, Inc. (the "Issuer").
The address of the principal executive office of the Issuer is One Possumtown
Road, Piscataway, New Jersey 08854.
Item 2. Identity and Background
(a) The person filing this statement is Mary Diehl.
(b) Ms. Diehl's residence is 13 Beverly Drive, Belle Mead, New Jersey
08502.
(c) Ms. Diehl is presently employed by the Foothill Acres Nursing Home,
Amwell Road, P.O. Box 780, Neshanick, New Jersey 08853.
(d) and (e) During the last five years, Ms. Diehl was not convicted in a
criminal proceeding and was not a party to a civil proceeding of a judicial
or administrative body of competent jurisdiction which as a result of such
proceeding was or is subject to a judgment, decree or final order enjoining
future violations of, or prohibiting or mandating activities subject to,
federal or state securities laws or finding any violation with respect to
such laws.
(f) Ms. Diehl is a United States citizen.
Item 3. Source and Amount of Funds or Other Consideration
Not Applicable.
Item 4. Purpose of Transaction
Ms. Diehl has no present plans or proposals which relate to or would result
in any of the events referred to in items (a) through (j) of Item 4, except that
Ms. Diehl may buy or dispose of additional shares of the Issuer's Common Stock
in the future.
Item 5. Interest in Securities of the Issuer
(a) Mary Diehl beneficially owns directly and indirectly an aggregate of
572,000 shares of Common Stock, constituting 4.35% of the outstanding Common
Stock.
(b) Mary Diehl has sole voting power and sole dispositive power with
respect to 572,000 shares. Ms. Diehl does not share voting or dispositive power
with respect to such shares.
(c) There have been no transactions of Common Stock involving Mary Diehl
during the past sixty days.
(d) Not applicable.
(e) From July 17, 1996 to November 26, 1997, Mary Diehl disposed
of an aggregate of 198,236 shares of Common Stock in open market transactions.
As a result, on October 3, 1997, Mary Diehl ceased to be the beneficial owner of
more than 5% of the Issuer's Common Stock.
<PAGE>
- ------------------------- --------------------------
CUSIP No. 762073104 Page 4 of 5 Pages
- ------------------------- --------------------------
13D/A
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer
Not applicable.
Item 7. Material To Be Filed As Exhibits
Not applicable.
<PAGE>
- ------------------------- --------------------------
CUSIP No. 762073104 Page 5 of 5 Pages
- ------------------------- --------------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
March 23, 1998 /s/ Mary Diehl
- ------------------------- --------------------------------
Date Mary Diehl
